[Measurement of peak inspiratory flow with asthma: effect of inhaled beta2-stimulant]

Nihon Kokyuki Gakkai Zasshi. 2005 Apr;43(4):216-20.
[Article in Japanese]

Abstract

This study was designed to evaluate peak inspiratory flow (PIF) and peak expiratory flow (PEF) in 24 patients with mild asthma. After inhalation of a beta2-stimulant (beta2), PIF significantly increased from 173.0 +/- 67.0 (range 70-300 L/min) to 194.0 +/- 66.7 after 1 minute, and to 199.3 +/- 63.0 after 15 minutes (p < 0.0025, and p < 0.008, respectively). PEF also significantly increased. The previous inhalation of beta2 improved the efficacy of inhalation of dry powder. This evidence should be considered in performing patient education for effective methods of inhalation.

Publication types

  • English Abstract

MeSH terms

  • Administration, Inhalation
  • Adrenergic beta-Agonists / administration & dosage*
  • Adrenergic beta-Agonists / therapeutic use
  • Adult
  • Anti-Asthmatic Agents / administration & dosage*
  • Anti-Asthmatic Agents / therapeutic use
  • Asthma / drug therapy
  • Asthma / physiopathology*
  • Female
  • Humans
  • Middle Aged
  • Nebulizers and Vaporizers
  • Peak Expiratory Flow Rate / drug effects*

Substances

  • Adrenergic beta-Agonists
  • Anti-Asthmatic Agents